Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-23

Clinical Trial Update: Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Loteprednol Etabonate Ophthalmic Ointment to vehicle for inflammation after cataract surgery; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loteprednol etabonate ophthalmic ointment (loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Ocular Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2010-09-23